3Pelclova D, Bartunkova J, Fenclova Z, et al. Asbestos exposure and antineutrophil cytoplasmic Antibody (ANCA) positivity [J]. Arch Environ Health, 2003, 58(10): 662-668.
4Weidanz F, Day CJ, Hewins P, et al. Recurrences and infections during ontinuous tmmunosuppressive therapy after begSnning dialysis in ANCA-associated vasculitis [J]. Am J Kidney Dis, 2007, 50(1): 36-46.
2Chen M,Yu F,Zhang Y,et al. Clinical and pathological characteristics of Chinese patients with antineutrophil cytoplasmic autoantibody associated systemic vasculitides:a study of 426 patients from a single centre[J]. Postgrad Med J,2005,81:723 -727.
3Cohen BA,Clark WF. Pauci-immune renal vasculitis : natural history, prognostic factors, and impact of therapy [ J ]. Am J Kidney Dis, 2000,36:914 - 924.
4Hagen EC, Andrassy K, Csernok E, et al. Development and standardization of solid phase assays for the detection of anti-neutrophil cytoplasmic antibodies(ANCA). A report on the second phase of an international cooperative study on the standardization of ANCA assays[J].J Immunol Meth,1996,196:1 - 15.
